Eterna Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 8
- Market Cap
- $9.6M
- Introduction
Eterna Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.
Lineage Cell Therapeutics: To Report Third Quarter 2024 Financial Results and Provide Business Update
Lineage Cell Therapeutics to report Q3 2024 financial results and provide business update on Nov 14, 2024, hosting a conference call and webcast at 4:30 p.m. ET/1:30 p.m. PT.
Lineage Cell Therapeutics to Present at the Maxim Group 2024 Virtual Healthcare Summit
Lineage Cell Therapeutics' CEO, Brian M. Culley, will present at the Maxim Group 2024 Virtual Healthcare Summit on Oct. 15, 2024, discussing the company's allogeneic cell therapies for unmet medical needs.
© Copyright 2025. All Rights Reserved by MedPath